Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease

Figure 1

Pathways contributing to steatosis. An imbalance between fatty acid uptake, de novo synthesis and elimination of free fatty acids through oxidation and secretion into the blood with very low density lipoprotein triglycerides (VLDL), contributes to the development of steatosis.